Dragana Petrushevska

Dragana Petrushevska

Auto-generated profile, based on publicly available information

Dragana Petrushevska


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2026 in Macedonian Journal of Chemistry and Chemical Engineering
Verified
Journal Article
Open access
MTMaja Todeska
Maja Todeska
DVDaniel Velickovski
Daniel Velickovski
MGMartina Gjorgjevska
Martina Gjorgjevska
DPDragana Petrushevska
Dragana Petrushevska
TTTeodora Tasevska
Teodora Tasevska
MCMaja Simonoska Crcarevska
Maja Simonoska Crcarevska
Metformin hydrochloride (MHCl) is administered at high doses and requires robust formulation strategies to balance rapid drug availability with controlled-release performance. This study applied a Quality by Design (QbD) framework to develop immediate-release (IR) and prolonged-release (PR) MHCl granules and to evaluate the impact of binder selection on product quality and release behavior. Formulations were produced via wet granulation using polyvinylpyrrolidone (PVP), gelatin, and pregelatinized starch 1500 as binders. PR granules were further coated with Eudragit® RS/RL using a fluid-bed process. Risk assessment tools (Ishikawa and FMECA) guided the identification of critical quality attributes (CQAs), critical material attributes (CMAs), and critical process parameters (CPPs). Compatibility studies confirmed the absence of drug–excipient interactions. All IR formulations demonstrated rapid dissolution (> 90% release within 5 min). Uncoated PR granules exhibited partial release control, while coated formulations showed binder-dependent differences in particle size distribution and dissolution performance. The gelatin-based PR formulation provided the most consistent release profile and the closest alignment with United States Pharmacopeia (USP) extended-release criteria, as it demonstrated low variability and minimal intermediate-point deviations. The study confirmed that binder selection was a high-impact critical material attribute for achieving robust prolonged-release MHCl granules within a QbD-driven development strategy.